|
|
Article: The Prevalence of Allergic Rhinitis in the Seven Major Markets Ranges from 7.9% (Spain) to 17.2% (France), but Only about Half of the Affected Population Currently Seek Treatment.
- Article from:
- Business Wire
- Article date:
- May 9, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c36758) has announced the addition of "Immunotherapy in Allergic Rhinitis - Moving Away from Injections" to their offering.
Allergic rhinitis affects between 15% and 20% of the population in the seven major markets. Currently available treatments focus on symptom relief; however, a significant number of allergic rhinitis patients with uncontrolled symptoms remain. Shorter, safer, and more convenient therapies currently in development may lead to a substantial market expansion.
Scope of this title:
-- Detailed break-down of the prevalence of allergic rhinitis by ...